Prototype · all patients and values are fictional · not medical advice · clinical content awaiting Dr. Kajal's approval
Patients Family view
Jee1 Health
Doctor view · 2-minute read

Rajiv Khanna 46 M

Andheri West, Mumbai · Referred by Dr. M. Shah (General physician (fictional))
Allergy: No known drug allergiesDraft · not approved
Summary

46 M, new HTN (Sep 2026) on amlodipine 5; home ~142/92. Smoker 10/day, BMI 31. TG 280, LDL 160, HDL 34, ALT 78/GGT 90 (fatty-liver pattern), HbA1c 6.3, uric acid 8.4, vit D 14.

AI-drafted from structured data → edited and approved by the doctor
Red flags & open actions
Rule thresholds pending Dr. Kajal
  1. 1BP above target — Home avg 142/92 vs target <130/80 on 1 BP drug(s)4 home readings
  2. 2Bad cholesterol: above target — Cholesterol – LDL 160 mg/dL (was 145)Lab 22 Oct
  3. 3Liver enzyme ALT: high — SGPT (Alanine Transaminase) 78 U/L (was 55)Lab 22 Oct
  4. 4Blood fats: high — Triglycerides 280 mg/dL (was 230)Lab 22 Oct
  5. 5Uric acid: high — Uric Acid, Serum 8.4 mg/dL (was 7.6)Lab 22 Oct
  6. 6Vitamin D: deficient — Vitamin D (25-Hydroxy) 14 ng/mLLab 22 Oct
Blood pressure
Home avg 142/92 (n=4)Clinic 146/94, P 84Target <130/80
Target851111371638 Sept19 Oct20 Oct21 Oct22 Oct24 Oct
Systolic Diastolic
Cardiometabolic labs · current vs previous
TestCurrentPreviousΔRef / target
Cholesterol – LDL160 Oct 26145 Nov 24▲<100 mg/dL
Non-HDL Cholesterol216 Oct 26192 Nov 24▲<130 mg/dL
Cholesterol – HDL34 Oct 2636 Nov 24▼40> mg/dL
Triglycerides280 Oct 26230 Nov 24▲<150 mg/dL
HbA1c6.3 Oct 265.9 Nov 24▲Normal %
Fasting Blood Sugar118 Oct 26104 Nov 24▲Low mg/dL
eGFR84 Oct 2690 Nov 24▼Severely reduced mL/min/1.73m²
Serum Creatinine1.1 Oct 261.05 Nov 24▲0.7–1.3 mg/dL
Potassium4.3 Oct 26—3.5–5.1 mmol/L
Sodium140 Oct 26—136–145 mmol/L
Uric Acid, Serum8.4 Oct 267.6 Nov 24▲3.5–7.2 mg/dL
TSH Ultrasensitive2.1 Oct 26—0.27–4.2 µIU/mL
Hemoglobin15.6 Oct 26—13–17 g/dL
SGPT (Alanine Transaminase)78 Oct 2655 Nov 24▲<41 U/L
Vitamin D (25-Hydroxy)14 Oct 26—Deficient ng/mL
Hover a row for what the test means. Full panel in the family view → All reports.
Review & approve

Tick all three checks to approve.

Medications
  • Amlodipine 5 mg Morning · since Sep 2026Adherent
Risk profile
Smokes ~10 a dayBMI 31Waist 104 cmPrediabetesHigh uric acidDesk job, long hoursMother: high BPBMI 31 · waist 104 cm
CV risk score: tool to be chosen by Dr. Kajal
History & previous tests
  • High blood pressure since Sep 2026 · Newly diagnosed
  • Fatty liver (on blood test) since 2026
  • High cholesterol and triglycerides since 2024 · Not on treatment
  • ECG (8 Sept 2026): Normal
  • Ultrasound abdomen: Not done; suggested for fatty liver
Assessment & plan sample text

Impression: Stage 2 hypertension, newly diagnosed, improving. Mixed dyslipidaemia. Probable MASLD (fatty liver). Prediabetes. Hyperuricaemia. Current smoker.

  • Smoking cessation (counselling ± pharmacotherapy)
  • [Doctor's decision on lipid therapy]
  • Structured weight-loss target 5–7%
  • Vitamin D replacement

Investigations: USG abdomen, Repeat lipids, HbA1c, LFT in 3 months

Next review: 14 Nov 2026